- Home
- MNMD vs PFIS Comparison
MNMD vs PFIS Comparison
Compare MNMD & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- PFIS
- Stock Information
- Founded
- MNMD 2019
- PFIS 1905
- Country
- MNMD United States
- PFIS United States
- Employees
- MNMD N/A
- PFIS N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- PFIS Major Banks
- Sector
- MNMD Health Care
- PFIS Finance
- Exchange
- MNMD Nasdaq
- PFIS Nasdaq
- Market Cap
- MNMD 709.9M
- PFIS 523.7M
- IPO Year
- MNMD N/A
- PFIS N/A
- Fundamental
- Price
- MNMD $9.44
- PFIS $52.51
- Analyst Decision
- MNMD Strong Buy
- PFIS
- Analyst Count
- MNMD 7
- PFIS 0
- Target Price
- MNMD $24.71
- PFIS N/A
- AVG Volume (30 Days)
- MNMD 1.1M
- PFIS 35.6K
- Earning Date
- MNMD 11-06-2025
- PFIS 11-04-2025
- Dividend Yield
- MNMD N/A
- PFIS 4.70%
- EPS Growth
- MNMD N/A
- PFIS 39.41
- EPS
- MNMD N/A
- PFIS 3.35
- Revenue
- MNMD N/A
- PFIS $165,604,000.00
- Revenue This Year
- MNMD N/A
- PFIS $70.81
- Revenue Next Year
- MNMD N/A
- PFIS $4.92
- P/E Ratio
- MNMD N/A
- PFIS $15.66
- Revenue Growth
- MNMD N/A
- PFIS 82.33
- 52 Week Low
- MNMD $4.70
- PFIS $38.90
- 52 Week High
- MNMD $11.02
- PFIS $59.70
- Technical
- Relative Strength Index (RSI)
- MNMD 50.26
- PFIS 54.06
- Support Level
- MNMD $8.70
- PFIS $52.08
- Resistance Level
- MNMD $9.95
- PFIS $53.98
- Average True Range (ATR)
- MNMD 0.56
- PFIS 1.05
- MACD
- MNMD -0.04
- PFIS -0.05
- Stochastic Oscillator
- MNMD 31.90
- PFIS 34.96
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.